Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study.
Click here for original story, Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
Source: ScienceDaily